- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Harvest Health & Recreation Reveals Safety Protocol for Vapes
Harvest Health announced a set of testing and safety protocols for THC vape products available at the company’s retail locations.
Harvest Health & Recreation (CSE:HARV,OTCQX:HRVSF) announced it was rolling out CannApprove, a set of testing and safety protocols for tetrahydrocannabinol (THC) vape products available at Harvest retail locations, on Thursday (November 14).
As quoted in the press release:
The CannApprove™ program represents a set of stringent seed-to-sale quality testing protocols developed and implemented during the past 10 years that Harvest products must pass before they are allowed on store shelves. The protocols are a demonstration of Harvest’s continued leadership role on quality and safety and will enhance the experience of patients and customers across the country.
All Alchemy™, Chroma™, Delta 8, Co2lors™ and CBx Sciences™ Amplify and Meditate vape products are manufactured in compliance with the CannApprove™ protocols, which apply to ingredients, components, hardware, manufacturing processes and packaging.
“Quality and safety are at the center of what we do and have done for nearly a decade,” said Harvest CEO Steve White. “CannApprove™ represents the rigorous steps and standards we employ to provide quality products for consumers and our patients. We go above and beyond the testing requirements in many jurisdictions where we operate and at a time when vaping products are under immense scrutiny, Harvest’s efforts demonstrate our leadership role over quality control.”
Click here to read the full press release.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.